Search

Microbiological Challenge Study Service

Creative Biolabs' Microbiological Challenge Study service measures whether live biotherapeutic formulations, packaging systems, and storage conditions resist or permit microbial contamination, giving formulation, QC/QA, packaging, and stability teams evidence for product-safety and shelf-life decisions. We design product-specific challenges, quantify organism recovery and change over time, define acceptance logic, and recommend formulation or packaging improvements.

Microbiological Challenge Testing Background and Product Risk Context

Live biotherapeutic formulations and adjacent probiotic, beverage, supplement, and pharmaceutical products can encounter adventitious microorganisms during filling, storage, distribution, or use. Product pH, water activity, nutrients, preservative strategy, container closure, and handling conditions may alter whether a contaminant declines, survives, or grows. A product-specific study provides empirical evidence when formulation attributes alone cannot resolve that risk.

Challenge testing deliberately introduces selected target organisms or scientifically justified surrogates at a controlled level, then tracks their recovery under defined conditions and time points. The resulting growth or inactivation profile supports safety, shelf-life, packaging, and microbial-control decisions. Creative Biolabs provides customized microbiological challenge study services that turn these variables into a traceable test plan and decision-ready report.1

What is microbiological challenge testing?

It is a controlled study that evaluates how intentionally inoculated microorganisms behave in a specific product under expected or justified storage and handling conditions.

Microbiological challenge study service

Microbiological Challenge Study Services for Formulation, Packaging, and Shelf Life

Our service is configured around the product, anticipated contamination route, intended storage profile, and the decision the study must support. Each plan connects organism selection and inoculation design to recoverability, sampling, quantitative interpretation, and practical development action.

01

Challenge Organism Strategy

Select target pathogens, spoilage organisms, or non-pathogenic surrogates according to product risks. Strain cocktails may be considered when they better represent biological variability, with rationale documented before execution.

02

Inoculum and Recovery Design

Define inoculum level, preparation, distribution, sample replication, controls, neutralization, and recovery checks. Method suitability is assessed so product matrix effects are not mistaken for genuine microbial decline.

03

Storage and Sampling Plan

Set temperatures, humidity or light exposure when relevant, in-use simulations, package orientation, and sufficient time points across the designated shelf life. Sample size and frequency are matched to the expected response.

04

Microbial Enumeration and Change

Quantify recoverable organisms at baseline and scheduled intervals. Results are expressed as change over time, enabling assessment of growth potential, maximum growth behavior, inhibition, or inactivation.

05

Acceptance Criteria and Interpretation

Predefine product-specific acceptance logic and interpret results against controls, recovery performance, variability, and formulation conditions. Deviations and inconclusive outcomes are identified transparently.

06

Formulation and Packaging Actions

Translate the microbial profile into practical recommendations, which may include preservation adjustments, barrier or closure changes, storage controls, shorter in-use windows, or focused confirmatory work.

Types of Challenge Studies

  • ✓Pathogen or target-organism growth inhibition studies
  • ✓Target-organism inactivation studies
  • ✓Combined growth and inactivation studies
  • ✓Preservation, packaging, and in-use simulation studies

Study Objectives and Sample Scope

Objectives

  • Assess growth potential of specific organisms
  • Estimate maximum growth rate where appropriate
  • Evaluate inhibition or inactivation over time
  • Compare formulations, packages, or storage profiles

Samples

  • Live biotherapeutic and probiotic formulations
  • Foods, ready-to-eat products, and acidified foods
  • Beverages and dietary supplements
  • Other aqueous or contamination-sensitive products

Microbiological Challenge Study Workflow

The workflow converts the core logic in the supplied challenge-study diagram into a traceable program with controlled execution, method recovery checks, and expert interpretation.

Stage 1

Design the Test

Confirm objective, matrices, packages, replication, controls, time points, reproducibility expectations, and acceptance criteria.

Stage 2

Prepare Inoculations

Prepare selected organisms, set inoculum size, verify culture condition, and establish inoculation and recovery methods.

Stage 3

Execute the Study

Inoculate test and control units, apply defined storage conditions, sample at scheduled intervals, and enumerate recovered organisms.

Stage 4

Interpret Results

Review recovery and organism change, compare results with acceptance logic, document limitations, and recommend next actions.

Microbiological Challenge Study Deliverables and Decision-Ready Reporting

Upon completion, Creative Biolabs issues a final report that connects raw observations with product-development decisions. Scope and reporting depth are agreed before study initiation.

Deliverable Included Content Decision Value
Approved Study Plan Organisms, strains or surrogates, inoculum level, sample units, controls, storage conditions, time points, methods, and acceptance logic. Creates alignment before samples and resources are committed.
Method Recovery Evidence Recovery checks, neutralization or matrix controls, suitability observations, deviations, and limitations. Separates genuine microbial behavior from method or matrix interference.
Microbial Change Profiles Time-point enumeration, log-change calculations, controls, descriptive trends, and comparisons across test conditions. Shows whether organisms decline, persist, or grow under the tested conditions.
Final Interpretation and Recommendations Acceptance assessment, study conclusions, risk interpretation, and formulation, packaging, storage, or follow-up recommendations. Turns test data into a practical product-control and development plan.

Sample Submission

Ready to submit samples for testing or method development? Complete the general test request form with product type, package configuration, storage conditions, available background data, and the decision your study must support.

Open Sample Submission Form

Case Study: Microbiological Safety and Stability of a Low-Acid Tea Product

This Creative Biolabs case study demonstrates how a targeted challenge design can answer a defined safety and stability question for a finished beverage formulation.

Microbiological challenge study case study
Download the Tea Product Case Study

Study Question and Product Profile

The study evaluated whether a low-acid tea beverage could remain microbiologically safe and stable after intentional challenge with proteolytic Clostridium botulinum. The product had an expected pH of 6.54, was packaged in hermetically sealed 550 mL PET bottles, and carried a 12-month ambient-temperature shelf-life target. The predefined acceptance criterion was the absence of detectable toxin formation during storage.

Creative Biolabs designed a challenge program using a cocktail of spores prepared from five proteolytic C. botulinum strains. The work included verification of toxin-production capability, heat shocking before inoculation, preparation and storage of test samples, microbiological and chemical analysis, and toxin analysis. The reported outcome showed stability against the challenge organism for six months at ambient temperature, providing formulation-specific evidence for safety assessment and development planning.

Objective Evaluate safety and stability of a low-acid tea product under a defined microbiological challenge.
Challenge Five-strain cocktail of proteolytic C. botulinum spores.
Analyses Microbiological and chemical measurements plus proteolytic C. botulinum toxin analysis.
Reported Result The challenged product was stable for six months at ambient temperature under the tested conditions.

Advantages of Creative Biolabs Microbiological Challenge Studies

A useful challenge study must do more than generate plate counts. Creative Biolabs connects experimental design, recoverability, product context, and interpretation so teams can act on the resulting evidence.

Product Safety Assurance

Determine whether a formulation supports survival or growth of relevant harmful or objectionable organisms.

Preservation Validation

Evaluate whether preservation and intrinsic product hurdles perform as intended under the selected challenge.

Quality Documentation

Receive a traceable study plan, controlled observations, deviations, calculations, and a clear final interpretation.

Shelf-Life Optimization

Understand microbial behavior under defined conditions to refine storage, package, and in-use controls.

Risk Identification

Identify weak points early enough to compare alternatives and reduce avoidable late-stage reformulation.

Flexible

Programs are configured for the product matrix, target organism, package, storage profile, and development question.

Integrated

Challenge work can connect with contaminant monitoring, quality control, stability, and final-product assays.

Actionable

Reports pair experimental results with clearly scoped formulation, packaging, storage, or follow-up recommendations.

Frequently Asked Questions About Microbiological Challenge Studies

Challenge studies are commonly considered when a product may be exposed to contamination and its formulation, preservation system, packaging, or storage conditions do not by themselves establish sufficient microbial control. Examples include:

  • Foods and beverages, including dairy, ready-to-eat meals, juices, and soft drinks
  • Liquid or other contamination-sensitive pharmaceutical products
  • Cosmetics and personal care products, especially water-containing formulations
  • Dietary supplements, probiotics, and related finished products
  • Selected medical devices or accessories with product-specific microbial risks

Organisms are selected according to the product, manufacturing environment, contamination route, and intended study question. Common challenge targets or model organisms may include:

Pathogenic or objectionable organisms

  • Escherichia coli O157:H7
  • Listeria monocytogenes
  • Salmonella enterica
  • Staphylococcus aureus
  • Bacillus cereus
  • Clostridium botulinum

Spoilage organisms

  • Yeasts and molds
  • Lactic acid bacteria
  • Acetic acid bacteria
  • Alicyclobacillus species

Where direct use of a target organism is unsuitable, a scientifically justified non-pathogenic surrogate with comparable behavior may be evaluated.

The data can support several connected product-development and quality decisions:

  • Product safety assurance
  • Shelf-life determination
  • Preservative efficacy evaluation
  • Quality-control strategy
  • Microbial risk assessment
  • Process and package validation planning
  • Formulation and product development
  • Storage and in-use instruction refinement

Selection depends on the study objective, expected contamination scenario, organism behavior, method quantification range, package and sample-unit constraints, shelf life, and planned storage profile. The design should include enough points to characterize early change and longer-term growth, persistence, or inactivation while maintaining appropriate controls and replication.

Useful inputs include the product composition and pH, water activity when available, preservative system, package and closure, manufacturing process, fill format, intended shelf life, storage and in-use conditions, known microbial risks, prior recovery or stability data, and the acceptance or development decision the study is expected to support.

Other Resources

Creative Biolabs Live Biotherapeutics service brochure cover. (Creative Biolabs Original)

Creative Biolabs' Live Biotherapeutics - Brochure

Probiotic strain products for next-generation probiotic research brochure. (Creative Biolabs Original)

Probiotic Strain Products for NGP Research - Brochure

Custom small-scale probiotic production brochure cover. (Creative Biolabs Original)

Custom Small-scale Probiotic Production - Brochure

Live biotherapeutics video presentation preview. (Creative Biolabs Original)

Live Biotherapeutics - Creative Biolabs - Video

Reference

  1. Hunt, Karen, et al. "Challenge studies to determine the ability of foods to support the growth of Listeria monocytogenes." Pathogens 7.4 (2018): 80. https://doi.org/10.3390/pathogens7040080
Online Inquiry

For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.

Creative Biolabs-Live Biotherapeutics


ISO 9001 Certified - Creative Biolabs Quality Management System.
Contact us
Solutions

Copyright © 2026 Creative Biolabs. All Rights Reserved.

Inquiry Basket